CPH
TARO

C Partners Holding’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

C Partners Holding’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,035
Closed -$102K – 224
2018
Q3 		$102K Sell
1,035
-1,119
-52% -$121K 0.04% 237
2018
Q2 		$249K Sell
2,154
-37
-2% -$4.06K 0.09% 49
2018
Q1 		$216K Sell
2,191
-143
-6% -$14.5K 0.09% 132
2017
Q4 		$244K Buy
+2,334
New +$256K 0.1% 239

Other funds holding TARO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
AL
AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return
FCH
Freestone Capital Holdings Seattle, Washington $3.3B AUM 21.14% 1-Year Est. Return

C Partners Holding's TARO Position: Q4 2018 in Review

C Partners Holding sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2018, closing a stake of 1,035 shares — an estimated $102K sold.

C Partners Holding first reported a position in TARO in Q4 2017 and held it in 4 quarters. The position peaked at $249K in Q2 2018. 94 funds tracked by Wall St. Rank hold TARO as of Q4 2018.

  • C Partners Holding reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2018 after selling out during the quarter.
  • C Partners Holding sold 1,035 Taro Pharmaceutical Industries Ltd. shares in Q4 2018, an estimated $102K.
  • C Partners Holding first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2017 and held it in 4 quarters.
  • C Partners Holding's Taro Pharmaceutical Industries Ltd. position peaked at $249K in Q2 2018.
  • 94 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2018.

Based on C Partners Holding's 13F filing for Q4 2018, filed 7 Feb 2019.